Navidea Biopharmaceuticals, Inc. (NAVBQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 5, 2026
Navidea Biopharmaceuticals Earnings Call Transcripts
Fiscal Year 2024
-
Stockholders approved amendments for written consent and a reverse stock split, with both proposals passing by majority vote. The company addressed SEC reporting risks, confirmed ongoing shareholder protections, and announced the suspension of a key clinical trial after unfavorable results.